ArticleOncotarget2016

DR5 mAb-conjugated, DTIC-loaded immuno-nanoparticles effectively and specifically kill malignant melanoma cells in vivo.

Baoyue Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.